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Abstract 
In vivo, articular chondrocytes produce an important amount of extracellular matrix (cartilage) whose quality is impaired upon 
inflammation or aging leading 1:o arthritis or arthrosis. Transglutaminases (EC 2.3.2.13) are a family of enzymes which have been shown 
to be involved in extracellular matrix stabilization, cell differentiation and possibly in initiation and propagation of inflammatory diseases. 
It is therefore of interest o svady transglutaminase activity in chondrocytes. Transglutaminase activity was studied in rabbit articular 
chondrocytes in primary culture, where cells are in a well-differentiated state as assessed by collagen-type synthesis, as well as in 
subculture and in retinoic acid-treated cells, where cells are in a dedifferentiated state. Results showed that two different TGases activities 
are expressed in chondrocytes. One, down-regulated upon retinoic acid treatment of cells, preferentially membrane bound and strongly 
activated upon trypsin treatment of cell lysates, is expressed at a high level in primary culture. The other one is up-regulated upon retinoic 
acid treatment, preferentially cytosolic and inactivated upon trypsin treatment of cell lysates. The rate of expression of the TGase 
down-regulated by RA seems 1o correlate with the differentiation state of the chondrocyte. This suggests that this TGase activity may 
have a physiological role in cartilage and merits further study. 
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1. Introduction 
Transglutaminases (TGases, protein-glutamine:amine 
y-glutamyl transferase, E.C 2.3.2.13) are a family of cal- 
cium-dependant enzymes catalysing the reaction of a pro- 
tein bound y-glutamyl residue with an amine group, lead- 
ing to cross-linked proteins via a glutamyl-lysine bond or 
proteins modified with polyamine residues [1]. Several 
distinct forms of TGases have been identified and most 
have now been cloned and sequenced (for recent review 
see Ref. [2]). They show different cellular localization; 
cytosolic for type II TGase, membrane-associated for type 
I TGase, extracellular for plasmatic factor XIIIa, a TGase 
formed from the zymogen Factor XIII, for example [2]. 
One cell can express more than one type of TGase. Their 
Abbreviations: TGase, transglutaminase; RA, all trans-retinoic a id; 
DTT, dithiothreitol; PMSF, phenylmethanesulphonyl fluoride; Tris-HCl, 
tris(hydroxymethyl)amino methane-hydrochloric acid; TCA, trichloro- 
acetic acid; PBS, phosphate buffered saline; SDS-PAGE, sodium dodecyl 
sulfate-polyacrylamide g l electrophoresis. 
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role has been defined in diverse biological functions such 
as the stabilization of fibrin structure in blood clotting by 
plasma factor XIIIa, the formation of cross-linked en- 
velopes during squamous cell differentiation by type I 
TGase, or the formation of apoptotic bodies during apopto- 
sis by type II TGase [2]. The common feature between 
these functions consists in the formation of highly cross- 
linked, lattice-type structures which are highly insoluble. 
This strongly suggests a role of TGases in the stabilization 
of extracellular matrix. In fact, extracellular matrix pro- 
teins such as fibronectin, fibrin(ogen), type III collagen, 
nidogen and involucrin have been shown to be substrates 
of TGases [2,3]. Moreover, type II TGase, the most studied 
TGase which has been identified in many cell types [4,5], 
has been suggested to be involved in many events which 
punctuate the cell life; growth [6], differentiation [7], apop- 
tosis [8], capacity to metastase [9,10]. More recently, 
TGases have been shown to be able to modulate, or even 
modify biological activity of proteins; phospholipases A2, 
involved in the initiation and propagation of several in- 
flammatory diseases such as rheumatoid arthritis, are 
strongly activated upon post-translational modification by 
TGases [11,12]; interleukin 2 becomes cytotoxic to oligo- 
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dendrocytes upon dimerization by TGases, a mechanism 
which may explain nervous regeneration [13]. 
The main biological function of articular chondrocytes 
is to produce the cartilage matrix, consisting of specific 
proteoglycans [14] and collagen types, mainly type II 
collagen [15]. Upon aging [16] or pathological conditions 
such as arthritis [17] or arthrosis [18], chondrocytes dedif- 
ferentiate and produce non-specific proteoglycans a well 
as type I collagen which impairs cartilage quality. Since 
TGases have been shown to be involved in extracellular 
matrix stabilization [2,3], cell differentiation [7,19], initia- 
tion and propagation of inflammatory diseases [11,12], 
they may be expressed and have a role in chondrocytes. To
address this issue, cultured articular chondrocytes, which 
dedifferentiate upon subculture [20], have been used as a 
model. Retinoic acid, inducing type II TGase expression i  
many cell types [2] while suppressing type I TGase in 
keratinocytes [19,21], is also a potent dedifferentiating 
agent in chondrocytes [22]. 
In this paper, TGase activity has been compared on one 
hand in primary culture, where chondrocytes are in a 
well-differentiated state, and on the other hand, in subcul- 
tured and RA-treated chondrocytes, two models of dedif- 
ferentiated chondrocytes. Results suggest that chondro- 
cytes express two different TGases whose expression de- 
pends on the differentiated state of the cell. Since TGases 
exhibit different sensitivities to trypsin as well as different 
cellular localization, we studied these points to better 
characterize the TGases and put forward hypotheses con- 
cerning their identity. 
2. Material and methods 
2.1. Material 
Ham's F12, Dulbecco's modified Eagle medium and 
PBS were purchased from Gibco-BRL and fetal calf serum 
from IBF. L-[5-3H]proline (20-50 Ci/mmol), [1,4(n)- 
3H]putrescine dihydrochloride and Amplify were obtained 
from Amersham. Hionic-Fluor was from Packard. 
Cyanogen bromide was purchased from Serva and all 
electrophoresis reagents and apparatus were from Biorad. 
All other reagents were from Sigma. 
2.2. Chondrocyte isolation and culture 
Articular chondrocytes from the shoulder and knee 
joints of 1- to 2-month-old Fauve de Bourgogne rabbits 
were isolated by sequential enzymatic digestion (trypsin 
and collagenase) of cartilage slices as described by Green 
[23]. Cells were seeded at 25 000 cells/cm 2 in Ham's FI2 
medium containing 10% fetal calf serum and 4 /zg/ml 
gentamicin. Cultures were maintained in a 37°C incubator 
in an atmosphere of 95% air and 5% CO 2 until confluency 
(6 days). Medium was changed two days after seeding. 
Upon confluence, cells were trypsinized and replated as 
described above. The medium was changed once during 
the incubation week needed to reach confluency. Confluent 
cultures were treated for 48 h with all-trans-retinoic acid at 
1 /xg/ml in culture medium from a 1-mg/ml stock solu- 
tion prepared in 95% ethanol, stored at -20  ° C. 
2.3. Transglutaminase assay 
Confluent cells grown in 100-mm culture dishes (2 
dishes per assay) were rinsed twice with 5 ml of ice-cold 
PBS (10 mM phosphate buffer (pH 7.5), 2,7 mM KCI, 137 
mM NaCI) and harvested by scraping the cell layers with a 
rubber policeman in 2 ml of ice-cold PBS and put into a 
15-ml tube kept on ice. Dishes were rinsed twice with 2 ml 
of PBS which was added to the 15-ml tube. Tubes were 
quickly centrifuged at 400Xg for 5 min at 4 °C, the 
supernatant was removed and pellets were stored at - 80 ° C 
until use. For total TGase activity determination, pellets 
were suspended in 0.5 ml of lysis buffer (5 mM Tris-HC1 
(pH 7.5), 0.25 M sucrose, 0.2 mM MgSO 4, 2 mM DTT, 
0.4 mM PMSF, 5 /xg/ml leupeptin and 0.4% Triton 
X-100) and sonicated (2 X 10 s at an amplitude of 7/xm). 
When cell fractionation was performed, Triton was 
omitted from the lysis buffer and cells were broken using a 
Potter-Elvehjem homogenizer. The cell lysate was frac- 
tionated into the cytosol and particulate fractions by cen- 
trifugation at 100000 × g for 1 h. The supernatant was 
adjusted to 0.4% Triton and used as the cytosol fraction. 
The pellet was suspended in 0.5 ml lysis buffer containing 
triton, sonicated and used as the particulate fraction. Con- 
tamination of the particulate fraction by the cytosolic 
fraction was corrected by measuring D-lactate dehydro- 
genase activity (EC 1.1.1.28.) in fractions according to the 
method of Bergmeyer et al. [24]. 
Proteolysis of cell lysates was carried out by adding 50 
/xg of trypsin per ml of protein lysate (approximately 0
ng of trypsin per /xg of protein) and by incubating the 
lysate for 15 min at 37 ° C. Soybean trypsin inhibitor (1.5 
/xg//zg trypsin) was added to stop proteolysis. 
The transglutaminase activity assay was based on the 
incorporation of radioactive putrescine into N,N'-dimethyl- 
casein. The incubation mixture containing 80 /xl of cell 
extract and 80/xl of TGase assay buffer (300 mM Tris-HCl 
buffer [pH 7.5], 10 mM CaC12, 20 mM DTT, 3 mM 
putrescine, 12.5 /xCi/ml [1,4(n)-3H]putrescine and 10 
mg/ml N,N'-dimethylcasein) was incubated for 30 min at 
37 ° C. Control samples received lysis buffer instead of cell 
lysates. The reaction was stopped by adding 4 ml of cold 
10% TCA containing 0.5% tannic acid. Pellets were rinsed 
twice with 4 ml of cold 10% TCA containing 0.25% tannic 
acid and finally dissolved into 0.1 ml of 1 M NaOH. 
Samples were then bleached with 0.9 ml of 2% hydrogen 
peroxide for 4 h and the remaining hydrogen peroxide was 
decomposed by heating at 40°C for 4 h. Samples were 
finally dissolved in 10 ml of Hionic-Fluor and counted in a 
Beckman liquid scintillation counter. 
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Enzyme activity was expressed as picomoles of pu- 
trescine incorporated per mg of protein for 30 min. Pro- 
teins were determined using the Bio-Rad protein assay and 
bovine serum albumin as standard. 
2.4. Collagen synthesis 
Confluent cultures in 25-cm 2 flasks were labelled for 
24 h with L-[5-3H]proline (50 /xCi/ml) in Dulbecco's 
modified Eagle medium containing 10% fetal calf serum 
supplemented with fl-aminopropionitrile (62.5/zg/ml)  and 
sodium ascorbate (25 /zg/:ml). Whole cultures were ad- 
justed to 0.5 M acetic acid ~md treated with 0.1 mg/ml  of 
pepsin at 4 ° C for 24 h. Pepsin was inactivated by the 
addition of Tris to 120 mM and by titration to pH 7.4 with 
10 N NaOH. NaC1 was added to 0.5 M (final [Na +] = 1 
M) and cultures were extracted at 4 ° C for 24 h. Debris 
were removed by centrifugation and the supernatant was 
adjusted to 10% FCS. Ammonium sulfate was adjusted to 
176 mg/ml ,  left for 48 h at 4 ° C for collagen precipitation, 
and centrifuged at 12 000 X g for 30 min. The collagen 
pellet was rinsed three times with 1 ml of 70% ethanol and 
finally dissolved in 0.5 ml of 0.5 N acetic acid. Cyanogen 
bromide cleavage of collagens was performed as described 
in Ref. [25]. Lyophilized s2mples of purified collagens or 
of collagens cleaved by cyanogen bromide were fraction- 
ated by 6% or 16% SDS-PAGE respectively as described 
in Ref. [26]. Gels were processed for fluorography using 
Amplify according to the manufacturer's instructions and 
exposed to Kodak XAR fihn at - 70 ° C. 
3. Results 
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Fig. 1. TGase activity in rabbit articular chondrocytes at different pas- 
sages expressed as pmol of putrescine incorporated per mg of protein in 
30 min. Untreated chondrocytes (0), retinoic acid-treated chondrocytes 
(O). Data points are the mean of triplicates of one representative 
experiment. 
almost only type II collagen as major type in primary 
cultures. Dedifferentiation is already almost complete at 
passage 4 where chondrocytes express type I and III 
collagen with hardly any type II collagen. 
When TGase activity is expressed with reference to cell 
number instead of mg of protein (Fig. 4a), TGase activity 
decreases harply between primary cultures and passage 3 
then remains almost stable up to passage 7. As shown in 
3.1. Transglutaminase activity in chondrocytes at different 
passages 
TGase activity was measured in chondrocytes from 
confluent primary cultures. (P0) up to passage 7 (P7), 
passage number at which tl'tey have almost completely lost 
their proliferation capacity. As can be seen in Fig. 1, 
TGase activity was high in primary culture (8000 pmol /mg 
of protein/30 min) and rapidly decreased uring the first 
two passages. At passage 2, the TGase activity was already 
only about 1300 pmol /mg/30  min and went on decreas- 
ing slowly at later passages to reach about 600 
pmol /mg/30  min at passage 7. 
Fig. 2 shows electrophoretic profiles of purified colla- 
gens extracted from cell cultures at different selected 
passages. The dedifferentiation starts as soon as the first 
passage where an ~2(I) band appears on 6% SDS-PAGE 
signing type I collagen synthesis. Since a~(I) and c~z(II) 
collagen chains migrate as a single band on SDS-PAGE, 
purified collagens were subjected to cyanogen bromide 
cleavage in order to discriminate c~1(I) from al( I I)  colla- 
gen chains. As can be seen in Fig. 3, chondrocytes express 
PO PI P2 P4 
RA + - + - + + 
I I I  
a 1 
a2 (I) 
Fig. 2. 6% SDS-PAGE of [3H]proline-labelled collagens purified from 
confluent cultures of chondrocytes in primary culture (P0) up to passage 
4 (P4). Cultures were treated or not by retinoic acid (RA) as indicated. 
Positions of type III collagen, oq and ~2(I) collagen chains are indicated 
by arrowheads. 
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P0 P2 P4 P0 
+ - + - + - 
CB 10 (H)> 
CB 11 (II)~ 
CB 8 (H) t> 
CB 9,7 
CB 12 (H)I> 
CB 7 (I) ~- 
CB 8 (I) ~" 
CB 5+9 (HI) 
CB 6 (I) ~" 
CB 3 (I) ~'- 
CB 4 (IH) 
imall CB (HI) 
,~ CB 10 (H) 
,~ CB 11 (H) 
< CB 8 (II) 
,~ CB 9,7 (H) 
Fig. 3. 16% SDS-PAGE of CNBr peptides from collagens purified from confluent cultures of chondrocytes in primary culture (P0), passage 2 (P2) and 
passage 4 (P4). Cultures were treated or not by retinoic acid (RA) as indicated. Type II collagen CNBr peptides (CB n (II)), indicated by open arrowheads, 
are present in cells expressing a differentiated phenotype. Type I and III collagen CNBr peptides (CB n (I) and CB n (III), respectively), indicated by 
closed arrowheads, are present when cells express a dedifferentiated phenotype. 
Fig. 4b, the cell number per confluent dish obviously 
decreases as the passage number increases, especially from 
passage 4. This reflects the size increase of the cells which 
is a general feature of senescent cells compared to young 
and actively dividing cells [27]. Therefore, TGase activity 
decreases as soon as type II collagen synthesis decreases 
while cells actively divide. In contrast, TGase activity is 
stable and low when cells become senescent and are fully 
dedifferentiated. 
3.2. TGase activity in retinoic acid-treated chondrocytes 
As shown in Figs. 2 and 3, RA treatment of cell 
cultures induced type 1II and type I collagen synthesis 
1000 7" 
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Fig. 4. TGase activity in rabbit articular chondrocytes atdifferent passages expressed as pmol of putrescine incorporated per 106 cells in 30 min (a), cell 
number per confluent dish as a function of passage number (b). Untreated chondrocytes (0) ,  retinoic acid-treated chondrocytes (©). Data points are the 
mean of triplicates of one representative experiment. 
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while type II collagen synthesis, a differentiation marker of 
chondrocytes, was rapidly ,;uppressed. Fig. 1 shows that 
TGase activity strongly decreased in RA-treated primary 
cultures compared to control cultures (5000 versus 8000 
pmol /mg/30 min, respectively), while it at least doubled 
from passage 2 compared to control cultures. A similar 
pattern was obtained when TGase activity was expressed 
with reference to cell number (Fig. 4). These results 
strongly suggest that two different TGase activities can be 
expressed in chondrocytes; one, down-regulated by RA, is 
preferentially associated with early passages while the 
other one, up-regulated by RA, is evidenced at later pas- 
sages. The relative proportion of each enzyme would vary 
with the passage number. 
3.3. Trypsin action on TGa:~e activity 
A few TGases (factor XIII, epidermal TGase) have 
been shown to be activated by proteases such as trypsin or 
thrombin while others are not [28]. Preliminary tests 
showed that trypsin treatment of cell lysates at 37 ° C lead 
to an increase of TGase activity. On the other hand, TGase 
activity in control cell lysates was found to be rapidly 
heat-inactivated at 37 ° C. In order to perform accurate 
measures, control cell lysates were therefore kept on ice 
while trypsinisation was performed. The real activity of 
control lysates is therefore only 36_  3% of the values 
presented in Fig. 5. At early passages, TGase activity was 
always enhanced after trypsinisation of cell lysates whether 
the cells were treated or not by retinoic acid. From passage 
2, TGase activity apparently decreased upon trypsin treat- 
ment in RA treated cells, whereas it still increased in 
untreated cells. These results uggest the presence of TGase 
activities of different sensitivities to trypsin, i.e., different 
molecular forms. 
3.4. TGase activity localization 
TGase activity localization was assessed on P0, P2 and 
P4 which represent the different states of differentiation of
the chondrocyte as well as the different behaviour of 
TGase activity towards RA or trypsin treatment. As shown 
in Fig. 6, TGase activity was mainly localized in the 
particulate fraction. Whether the cells were treated or not 
by RA, the percentage of total TGase activity found in the 
particulate fraction increased with passage number. How- 
ever, the percentage of total TGase activity in the particu- 
late fraction decreased upon RA treatment of cell cultures 
compared to control cells. Therefore, subculture and RA 
treatment, which both induce chondrocyte dedifferentia- 
tion, have opposite ffects with regard to the evolution of 
the percentage of total TGase activity found in the particu- 
late fraction. 
As shown in Fig. 7, when TGase activity is expressed, 
for each fraction, as a percentage of the TGase activity 
measured in control P0, it is clear that the TGase activity 
in the particulate fraction is stable from P2 (about 25% of 
initial activity) while the activity in the cytosol fraction 
still decreases to reach 1% of the initial activity at P4. 
Therefore, the increase in the percentage of total TGase 
activity in the particulate fraction between P2 and P4, seen 
in Fig. 6, is due to a specific decrease of the cytosol 
fraction activity, the particulate fraction activity being 
stable. 
In RA-treated cells, the TGase activity in the cytosol 
fraction always increased compared to control cells what- 
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Fig. 5. Effect of trypsin treatmen! of cell lysates on TGase activity in rabbit articular chondrocytes at different passages. Results are expressed as pmol of 
putrescine incorporated per mg of protein in 30 min. Untreated chondrocytes (a), RA-treated chondrocytes (b). Trypsin-treated cell lysates (dotted line), 
control cell lysates (continuous line). Data points are the mean of triplicates of one typical experiment. 
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Fig. 6. Percentage of total TGase activity localized in the particulate 
fraction of rabbit articular chondrocytes in primary culture, passage 2 and 
passage 4. Retinoic acid-treated cultures (hatched bars), control cultures 
(black bars). Mean + S.D. of two experiments performed in triplicate. 
ever the passage number (Fig. 7b). However, in the partic- 
ulate fraction, TGase activity decreased in primary culture 
whereas it increased at later passages (Fig. 7a). Therefore, 
the overall decrease of TGase activity observed in P0 after 
RA treatment seen in Fig. 1 seems to be the consequence 
of a decrease of the activity in the particulate fraction, 
which is not made up with an increase in the cytosol 
fraction (Fig. 7). At subsequent passages, the overall in- 
crease of TGase activity after RA treatment compared to 
control cells seen in Fig. l is due to an increase of TGase 
activity in both fractions, the increase in the cytosolic one 
being much more important han in the particulate one 
(Fig. 7). These results show that the TGase activity down- 
regulated by RA is preferentially membrane-associated 
whereas the TGase activity up-regulated by RA is prefer- 
entially localized in the cytosol. In other words, the dedif- 
ferentiation induced by subculture or by retinoic acid on 
primary cultures is in correlation with the decrease of 
TGase activity in the particulate fraction. 
4. Discussion 
Results presented in this paper suggest hat chondro- 
cytes can express two different TGases whose main differ- 
ence is based on the fact that their activities are regulated 
in opposite directions when cells are treated with retinoic 
acid. 
The TGase activity down-regulated by retinoic acid 
treatment is expressed at a high level in primary culture, is 
strongly activated by trypsin and is preferentially mem- 
brane-associated. Its expression may be related to the 
differentiation state of the chondrocyte since subculture 
leads to a parallel decrease of TGase activity and type I1 
collagen expression. 
From passage 2, TGase activity was low and also prone 
to trypsin activation. Upon RA treatment of these cell 
cultures, TGase activity at least doubled compared to 
untreated cells and was apparently inactivated upon trypsin 
treatment of cell lysates. This suggests that the TGase 
activity induced upon RA treatment of cells is not a simple 
,-~ 100 4 • 160 
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Fig. 7. TGase activity in the particulate fraction (a) and in the cytosol fraction (b) of rabbit articular chondrocytes at different passages. TGase activity is 
expressed, for each fraction, as the percentage of the activity measured in control primary cultures. Retinoic acid-treated chondrocytes (O), control cells 
(0).  Mean + S.D, of two experiments performed in triplicate. 
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global increase of the preexisting enzymes but rather a 
specific increase of one TGase form which, as shown in 
Figs. 6 and 7, mainly localizes in the cytoplasmic fraction. 
Taken together, these results uggest that chondrocytes can 
express type II TGase, if not constitutionally, at least after 
RA treatment since (1) type II TGase is positively regu- 
lated by retinoic acid [2], (:2) it is not activated by trypsin 
[28] but trypsin treatment of cell lysates containing type II 
TGase inactivates the enzyme [6], (3) it is a cytosolic 
enzyme but a part can also be found in the particulate 
fraction since it binds strongly to fibronectin [29], an 
extracellular matrix protein which is expressed in subcul- 
tured chondrocytes a well as in RA-treated chondrocytes 
[301. 
Concerning the activity :found in primary culture, results 
do not permit the suggestion of which type of TGase is 
responsible for this activity, partly because data from 
literature are somewhat conflicting. This TGase activity 
has common features (activation by trypsin, membrane 
bound) with the B enzyme: purified from rat swarm chon- 
drosarcoma,  tumour expressing many characteristics of
differentiated chondrocytes [31]. In their recent review, 
Aeschlimann and Paulsson [2] indicated that the B enzyme 
was type I TGase. Interestingly, type I TGase is down-reg- 
ulated by RA in keratinocytes [19,21] as we showed for 
TGase activity in chondrocytes in primary culture. How- 
ever, one point remains obscure: type I TGase is not 
activated by trypsin [28] whereas the B enzyme [31] and 
TGase activity of chondrocytes in primary culture are. 
In their recent paper, Aeschlimann et al. [32] did not 
find any TGase activity in calf tibial articular cartilage 
homogenates while we diA in cell lysates from cultured 
rabbit articular chondrocytes (Fig. 1), as well as from 
freshly isolated cells (data not shown). The use of pro- 
teinase inhibitors in cell isolation may explain this discrep- 
ancy: besides trypsin activation (Fig. 5), we found that 
TGase activity was lower when cells were directly col- 
lected in lysis buffer (containing proteases inhibitors) than, 
as described in Section 2, in PBS (which permits more 
complete cell collection). The latter procedure to prepare 
cell lysates may therefore not totally inhibit trypsin-like 
activities which permits TGase activity to break out. Con- 
sequently, the existence of an inactive form of transglutam- 
inase in chondrocytes may be possible, as has been de- 
scribed in metastasing tumours [33]. Whether this mem- 
brane-associated TGase is a different gene product or a 
precursor form, of the cytosolic form, for example, re- 
mains to be answered. 
In brief, whatever the exact identity of the TGases 
responsible for the enzymatic activity detected, we have 
shown that two different l'Gase activities are expressed in
rabbit articular chondrocytes. They differ in many points: 
time of expression in culture, regulation by retinoic acid, 
trypsin sensitivity and cellular localization. This suggests a
different role of these TGases in the physiology of the 
chondrocyte. 
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